The sesquiterpene lactone components of Cichorium glandulosum suppress both in vitro and in vivo inflammatory responses by reducing IL-1β levels
Inflammopharmacology · 2026
DOI: 10.1007/s10787-025-02076-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, 2026. Verfasst von Xiaoyan Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xinjiang Medical University, Urumqi, 830011, China. Hauptthemen laut MEDLINE: Lactones, Sesquiterpenes, Interleukin-1beta, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Department of Xinjiang Uygur Autonomous Region.
Abstract (Originalsprache)
This study investigates the anti-inflammatory effects and molecular targets of the chemical components in Cichorium glandulosum. Active compounds were isolated and purified from the ethyl acetate extract of Cichorium glandulosum, and their anti-inflammatory effects were evaluated using both in vitro and in vivo models. The results demonstrated that sesquiterpene lactones in Cichorium glandulosum possess significant anti-inflammatory properties. Molecular docking and biofilm interference analysis revealed that these compounds, particularly compound 4 (Lactucin) and compound 7 (Lactucopicrin), exhibit high affinity for IL-1β, interacting through hydrogen bonds and van der Waals forces, thus inhibiting inflammation. In vitro experiments showed that Lactucin and Lactucopicrin notably reduced the release of NO, IL-6, TNF-α, and IL-1β in LPS-stimulated RAW264.7 cells, highlighting their potent anti-inflammatory activity. Animal studies further confirmed the anti-inflammatory effects of these compounds in an acute inflammation model, with Lactucopicrin demonstrating superior anti-inflammatory efficacy compared to the positive control, indomethacin. Structure-activity relationship studies identified the α-methylene-γ-lactone group in sesquiterpene lactones as the key pharmacophore responsible for their anti-inflammatory activity. In conclusion, sesquiterpene lactones in Cichorium glandulosum inhibit inflammation by targeting IL-1β, demonstrating significant anti-inflammatory potential and providing new theoretical insights into the pharmacological research of active components in Cichorium glandulosum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xinjiang Medical University, Urumqi, 830011, China.
- School of Pharmacy, Xinjiang Medical University, Urumqi, 830011, China. mxl108@sohu.com.
- Key Laboratory of Active Components of Xinjiang Natural Medicine and Drug Release Technology, Urumqi, 830000, China. mxl108@sohu.com.
Förderung
- Science and Technology Department of Xinjiang Uygur Autonomous Region
Zitieren
APA
Ma, X., Li, Y., Qi, S., Zhang, C., Zhang, J., Pang, T., Hou, W., & Ma, X. (2026). The sesquiterpene lactone components of Cichorium glandulosum suppress both in vitro and in vivo inflammatory responses by reducing IL-1β levels. Inflammopharmacology. https://doi.org/10.1007/s10787-025-02076-3
Vancouver
Ma X, Li Y, Qi S, Zhang C, Zhang J, Pang T, et al. The sesquiterpene lactone components of Cichorium glandulosum suppress both in vitro and in vivo inflammatory responses by reducing IL-1β levels. Inflammopharmacology. 2026. doi:10.1007/s10787-025-02076-3
BibTeX
@article{Ma2026,
author = {Ma, Xiaoyan and Li, Yang and Qi, Shuwen and Zhang, Chunzi and Zhang, Juan and Pang, Tuxia and Hou, Wenhui and Ma, Xiaoli},
title = {The sesquiterpene lactone components of Cichorium glandulosum suppress both in vitro and in vivo inflammatory responses by reducing IL-1β levels},
journal = {Inflammopharmacology},
year = {2026},
doi = {10.1007/s10787-025-02076-3}
}
EUVIMED